癌症和糖尿病之间的交叉对话:探索细胞代谢和信号传递中共享的分子通路
Zhangzhi Tang1, Nuo Xu1, Pin Lyu2
1Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
Molecular aspects of medicine
|October 28, 2025
概括
2型糖尿病通过改变新陈代谢和促进炎症增加癌症风险. 了解这些联系,包括高血糖和高胰岛素血症,是开发针对糖尿病相关瘤的向治疗的关键.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 代谢研究研究 代谢研究
背景情况:
- 糖尿病和癌症是全球领先的慢性疾病,具有共同的代谢失调.
- 2型糖尿病是众所周知的多种癌症的风险因素.
- 了解糖尿病和癌症之间的分子联系对于患者的治疗结果至关重要.
研究的目的:
- 审查糖尿病病理生理学和瘤发生之间的分子交叉点.
- 突出高胰岛素血症和高血糖在瘤发育中的作用.
- 讨论对癌症治疗和未来研究的影响.
主要方法:
- 文献综述专注于分子机制.
- 对连接糖尿病和癌症风险的流行病学证据的分析.
- 检查新陈代谢重编程通路 (HBP,AGE).
主要成果:
- 超胰岛素血症和高血糖症通过代谢重编程驱动瘤的开始和进展.
- 关键的途径包括胺生物合成途径 (HBP) 的激活和高级糖化最终产品 (AGEs) 的积累.
- 糖尿病改变了瘤微环境 (TME),破坏了免疫功能,并通过表观遗传变化,UPR激活和肠道微生物群变化促进了癌细胞的生存.
结论:
- 糖尿病通过共同的代谢途径显著影响癌症的发展和进展.
- 抗糖尿病药物在癌症治疗中可能具有双重作用,需要仔细考虑.
- 需要多种omics方法来个性化治疗糖尿病相关癌症患者.
相关概念视频
Psychoneuroimmunology: Diabetes and Cancer
432
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
432
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K


